Patents by Inventor Charles Cant

Charles Cant has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROXIMAL MARKERS OF ARTERIAL THROMBOSIS AND INFLAMMATION FOR RISK STRATIFICATION OF CORONARY HEART DISEASE
    Publication number: 20060286681
    Abstract: The present invention relates to a method for establishing a diagnosis if an individual has suffered from or a prognosis if an individual is at risk of suffering from a coronary heart event, which method comprises determining the concentration of sCD40L in a body fluid of the individual; determining the concentration of a proximal inflammatory marker, preferably PAPP-A or Lp-PLA2 comparing the values obtained with reference values; and establishing the diagnosis or the prognosis in respect to the cardiovascular event. The combination according to the invention can be used with further markers selected from further inflammatory markers, anti-inflammatory markers and/or neurohumoral markers.
    Type: Application
    Filed: May 8, 2006
    Publication date: December 21, 2006
    Inventors: Hans-Peter Lehmann, Iris Fuehling, Charles Cant, Klaus Hallermayer
  • Antibodies directed against signal regulator proteins
    Patent number: 6913894
    Abstract: Monoclonal antibodies which bind specifically to the extracellular domain of the SIRP cell surface glycoproteins, and which, in some cases, block the interaction of SIRP with the surface molecule CD47, are described.
    Type: Grant
    Filed: May 29, 2002
    Date of Patent: July 5, 2005
    Assignee: Eberhard-Karls-Universitat Tubingen Universitatsklinikum
    Inventors: Hans-Jörg Bühring, Axel Ullrich, Zhengjun Chen, Charles Cant
  • Antibodies directed against signal regulator proteins
    Publication number: 20030054415
    Abstract: Monoclonal antibodies which bind specifically to the extracellular domain of the SIRP cell surface glycoproteins, and which, in some cases, block the interaction of SIRP with the surface molecule CD47, are described.
    Type: Application
    Filed: May 29, 2002
    Publication date: March 20, 2003
    Inventors: Hans-Jorg Buhring, Axel Ullrich, Zhengjun Chen, Charles Cant